Physician
Torrance Memorial Medical Center
Torrance Memorial Medical Center was paid $4.42M by Medicaid between Jan 2018 and Nov 2024, across 175 billing codes. Its largest line is 0121, — 11% of everything it billed.
33Billing provider infoTORRANCE MEMORIAL MEDICAL CENTER
TORRANCE, CA 90505
TORRANCE, CA 90505
33aNPI1477502797assigned 05/06/2006
33bProvider typeEmergency Medicine Physician
28Total paid$4.42M
24GClaims349,658
24DCodes billed175
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Emergency Medicine Physician providers in California
Rank by total paid#120 of 988
Median peer was paid$32K
This provider vs. median139×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,538 | $241K | |
| 2019 | 32,598 | $802K | |
| 2020 | 26,325 | $276K | |
| 2021 | 42,474 | $555K | |
| 2022 | 68,139 | $1.06M | |
| 2023 | 78,232 | $898K | |
| 2024incomplete | 68,352 | $582K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0121 | 11% | 830 | 758 | $481K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 10% | 7,183 | 6,291 | $461K |
| 0450 | Emergency room services | 10% | 27,890 | 24,937 | $451K |
| 0214 | 7.4% | 857 | 784 | $329K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 7.2% | 42,030 | 36,450 | $319K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 7.1% | 7,807 | 7,521 | $314K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.8% | 8,218 | 7,469 | $255K |
| 71045 | Radiologic examination, chest; single view | 5.2% | 45,755 | 37,622 | $228K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 2,686 | 2,593 | $137K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 3.0% | 2,589 | 2,502 | $134K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 4,134 | 3,869 | $91K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.6% | 2,173 | 2,054 | $69K |
163 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 5,452 | $69K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 3,908 | $61K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.3% | 2,151 | $59K |
| 0250 | 1.3% | 4,274 | $56K | |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 5,719 | $55K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 12,957 | $45K |
| 0300 | <1% | 3,354 | $44K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,942 | $42K |
| 76830 | Ultrasound, transvaginal | <1% | 1,488 | $41K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,521 | $41K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 819 | $37K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,509 | $33K |
| 93970 | <1% | 776 | $27K | |
| 93971 | <1% | 1,046 | $25K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 758 | $25K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,216 | $24K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,150 | $23K |
| 87631 | <1% | 729 | $21K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 827 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,337 | $19K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 760 | $17K |
| 80076 | <1% | 5,589 | $17K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 332 | $17K |
| 84484 | <1% | 3,608 | $16K | |
| 81025 | <1% | 5,724 | $16K | |
| 99284 | Emergency room visit (serious) | <1% | 956 | $15K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 574 | $15K |
| 83690 | <1% | 4,536 | $12K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,498 | $12K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 307 | $12K |
| 81002 | <1% | 7,771 | $11K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,229 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 646 | $8K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 632 | $8K |
| 73630 | <1% | 900 | $7K | |
| 83880 | <1% | 909 | $7K | |
| 76801 | <1% | 287 | $7K | |
| 72100 | <1% | 718 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 988 | $6K |
| 73610 | <1% | 707 | $6K | |
| 27502 | <1% | 107 | $6K | |
| 76770 | <1% | 294 | $6K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 69 | $6K |
| 73030 | <1% | 763 | $5K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,654 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,129 | $5K |
| 0510 | <1% | 375 | $5K | |
| 0270 | <1% | 2,203 | $4K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 247 | $4K |
| 73130 | <1% | 350 | $4K | |
| 83605 | <1% | 1,076 | $4K | |
| 85610 | <1% | 2,712 | $4K | |
| 81001 | <1% | 2,378 | $4K | |
| 71250 | <1% | 153 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,306 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 299 | $3K |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 577 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 299 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,074 | $3K |
| 87088 | <1% | 878 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 124 | $3K |
| 85730 | <1% | 1,473 | $3K | |
| 84702 | <1% | 526 | $3K | |
| 73562 | <1% | 365 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 53 | $3K |
| 87040 | <1% | 485 | $2K | |
| 74018 | <1% | 543 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 155 | $2K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 44 | $2K |
| A4649 | Surgical supply; miscellaneous | <1% | 2,357 | $2K |
| J3490 | Unclassified drugs | <1% | 4,912 | $2K |
| 73560 | <1% | 411 | $2K | |
| 99285 | Emergency room visit (most serious) | <1% | 65 | $2K |
| 87077 | <1% | 674 | $2K | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 471 | $2K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 74 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 143 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 96 | $2K |
| 85378 | <1% | 466 | $1K | |
| 0271 | <1% | 438 | $1K | |
| 0370 | <1% | 807 | $1K | |
| 70486 | <1% | 26 | $1K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 26 | $1K |
| 87186 | <1% | 377 | $1K | |
| 73110 | <1% | 141 | $1K | |
| 0272 | <1% | 7,255 | $1K | |
| 0320 | <1% | 1,779 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,899 | $1K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 53 | $1K |
| 86901 | <1% | 643 | $1K | |
| 83735 | <1% | 481 | $1K | |
| 73502 | <1% | 164 | $991.46 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 418 | $966.76 |
| 88342 | <1% | 65 | $921.72 | |
| 80053 | Comprehensive metabolic panel | <1% | 219 | $861.59 |
| 82947 | <1% | 436 | $758.98 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 110 | $753.75 |
| 86140 | <1% | 461 | $750.21 | |
| 80306 | <1% | 252 | $727.59 | |
| 84145 | <1% | 130 | $682.39 | |
| 0730 | <1% | 1,489 | $610.00 | |
| 94664 | <1% | 88 | $603.89 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 62 | $600.00 |
| 86900 | <1% | 483 | $551.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 306 | $540.87 |
| 93880 | <1% | 24 | $522.69 | |
| 0259 | <1% | 1,363 | $458.51 | |
| 86077 | <1% | 16 | $424.97 | |
| 0637 | <1% | 16,090 | $405.31 | |
| 99283 | Emergency room visit (moderate) | <1% | 26 | $383.82 |
| 0258 | <1% | 5,416 | $294.66 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 185 | $286.06 |
| 71020 | <1% | 24 | $269.15 | |
| 0710 | <1% | 348 | $260.78 | |
| 73140 | <1% | 55 | $245.52 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 70 | $242.77 |
| 71010 | <1% | 32 | $235.43 | |
| 76642 | <1% | 13 | $165.40 | |
| 0360 | <1% | 112 | $146.17 | |
| 72040 | <1% | 26 | $141.71 | |
| 96368 | <1% | 14 | $135.30 | |
| 77001 | <1% | 15 | $128.02 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 136 | $94.55 |
| 86850 | <1% | 31 | $84.22 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 57 | $83.88 |
| 76937 | <1% | 13 | $75.10 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $63.85 |
| 82077 | <1% | 12 | $54.72 | |
| 82550 | <1% | 26 | $44.84 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 16 | $44.22 |
| 80320 | <1% | 14 | $38.70 | |
| 87430 | <1% | 12 | $33.62 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 83 | $24.93 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 27 | $21.69 |
| 85652 | <1% | 25 | $18.69 | |
| 83615 | <1% | 14 | $16.46 | |
| 82553 | <1% | 12 | $14.26 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $8.84 |
| A4565 | Slings | <1% | 25 | $4.38 |
| 0402 | 0% | 368 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 237 | $0.00 |
| 0260 | 0% | 1,000 | $0.00 | |
| 0483 | 0% | 95 | $0.00 | |
| 0460 | 0% | 68 | $0.00 | |
| 0424 | 0% | 56 | $0.00 | |
| 0412 | 0% | 96 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 86 | $0.00 |
| 0351 | 0% | 15 | $0.00 | |
| 0921 | 0% | 46 | $0.00 | |
| 0430 | 0% | 16 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 96376 | 0% | 307 | $0.00 | |
| 0352 | 0% | 534 | $0.00 | |
| 0420 | 0% | 58 | $0.00 | |
| 0636 | 0% | 45 | $0.00 | |
| 0310 | 0% | 102 | $0.00 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 0% | 234 | $0.00 |
| 0720 | 0% | 31 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 46 | $0.00 |
| 0721 | 0% | 29 | $0.00 | |
| 0171 | Inj, epinephrine (belcher) | 0% | 29 | $0.00 |
| 0471 | 0% | 30 | $0.00 | |
| 0434 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARSON, WILLIAM (VICE PRESIDENT FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Wadena Family Dental, P. A. | Wadena, MN | $42K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.